Cargando…

Visual and quantitative evaluation of [(18)F]FES and [(18)F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

PURPOSE: Correct identification of tumour receptor status is important for treatment decisions in breast cancer. [(18)F]FES PET and [(18)F]FDHT PET allow non-invasive assessment of the oestrogen (ER) and androgen receptor (AR) status of individual lesions within a patient. Despite standardised analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mammatas, Lemonitsa H., Venema, Clasina M., Schröder, Carolina P., de Vet, Henrica C. W., van Kruchten, Michel, Glaudemans, Andor W. J. M., Yaqub, Maqsood M., Verheul, Henk M. W., Boven, Epie, van der Vegt, Bert, de Vries, Erik F. J., de Vries, Elisabeth G. E., Hoekstra, Otto S., Hospers, Geke A. P., der Houven van Oordt, C. Willemien Menke-van
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167394/ https://www.ncbi.nlm.nih.gov/pubmed/32307594 http://dx.doi.org/10.1186/s13550-020-00627-z

Ejemplares similares

Diagnostic Performance of [(18)F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Iqbal, Ramsha, et al.
Publicado: (2021)

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
por: van Kruchten, Michel, et al.
Publicado: (2015)

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using (18)F-FES PET/CT imaging
por: Jager, Agnes, et al.
Publicado: (2020)

Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021)

Enhanced pulmonary uptake on (18)F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?
por: Venema, C. M., et al.
Publicado: (2019)

Fluorine-18 Labeled Fluorofuranylnorprogesterone ([(18)F]FFNP) and Dihydrotestosterone ([(18)F]FDHT) Prepared by “Fluorination on Sep-Pak” Method
por: Basuli, Falguni, et al.
Publicado: (2019)

Image Quality and Interpretation of [(18)F]-FES-PET: Is There any Effect of Food Intake?
por: Boers, Jorianne, et al.
Publicado: (2020)

[(18)F]FES uptake in the pituitary gland and white matter of the brain
por: Iqbal, R., et al.
Publicado: (2021)

Early (18)F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
por: van Helden, Erik J., et al.
Publicado: (2016)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

[(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2023)

[(18)F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma
por: Orevi, Marina, et al.
Publicado: (2021)

Radiomics analysis of pre-treatment [(18)F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
por: van Helden, E. J., et al.
Publicado: (2018)

Clinical-grade N-(4-[(18)F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans
por: van der Veen, Elly L., et al.
Publicado: (2019)

Monitoring HSVtk suicide gene therapy: the role of [(18)F]FHPG membrane transport
por: Buursma, A R, et al.
Publicado: (2004)

Molecular imaging as biomarker for treatment response and outcome in breast cancer
por: van Geel, Jasper J. L., et al.
Publicado: (2023)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

Myocardial Metastases on 6-[(18)F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients
por: Noordzij, Walter, et al.
Publicado: (2014)

Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review
por: de Vries, Bart M., et al.
Publicado: (2023)

Semi-Quantitative and Quantitative [(18)F]FDG-PET/CT Indices for Diagnosing Large Vessel Vasculitis: A Critical Review
por: Gheysens, Olivier, et al.
Publicado: (2021)

Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [(18)F]Flortaucipir and [(18)F]Florbetapir Brain PET Studies
por: de Vries, Bart M., et al.
Publicado: (2021)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

The Use of (18)F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2013)

Successful Trastuzumab-Deruxtecan Rechallenge After Interstitial Lung Disease: A Case Report
por: de Weger, Vincent A., et al.
Publicado: (2023)

Variability of [(18)F]FDG-PET/LDCT reporting in vascular graft and endograft infection
por: Liesker, David J., et al.
Publicado: (2023)

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
por: Mammatas, L. H., et al.
Publicado: (2020)

Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2020)

A resting-state fMRI pattern of spinocerebellar ataxia type 3 and comparison with (18)F-FDG PET
por: van der Horn, Harm J., et al.
Publicado: (2022)

Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
por: Lima Ferreira, Joana, et al.
Publicado: (2021)

In vitro imaging of bacteria using (18)F-fluorodeoxyglucose micro positron emission tomography
por: Heuker, Marjolein, et al.
Publicado: (2017)

[(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2023)

Relationship between semiquantitative (18)F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma
por: Kahle, X. U., et al.
Publicado: (2019)

Interobserver reproducibility of tumor uptake quantification with (89)Zr-immuno-PET: a multicenter analysis
por: Jauw, Yvonne W. S., et al.
Publicado: (2019)

Manifestation of lymphoma expansion following lymphatic drainage on (18)F-FDG PET/CT
por: Eshuis, Silvia A., et al.
Publicado: (2011)

Publisher Correction: In vitro imaging of bacteria using (18)F-fluorodeoxyglucose micro positron emission tomography
por: Heuker, Marjolein, et al.
Publicado: (2019)

Noise sensitivity of (89)Zr-Immuno-PET radiomics based on count-reduced clinical images
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

Uptake of (18)F-fluoro-2-deoxyglucose in the Healthy Testes of Young Men as Assessed by Positron Emission Tomography/Computed Tomography; Including the Inter- and Intra-observer Variation
por: Meij-de Vries, A., et al.
Publicado: (2014)

Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis
por: van der Geest, K. S. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2104i66dh0gruras1najv6ulu7